T cell receptor (TCR) diversity is clearly related to protection from infection. However, the characteristics of TCR diversity in neonates are not clear. In this study, we investigated the TCR diversity of neonates with sepsis. Twenty neonates with severe sepsis and eight matched neonates without infection were enrolled in the study. For the neonates with sepsis, EDTA-anticoagulated blood was collected on day 1 after the diagnosis of sepsis and on day 7 of treatment. For the neonates without infection, blood was collected one time. DNA was extracted from peripheral blood mononuclear cells. The complementarity determining region 3 (CDR3) gene was analysed by multiplex PCR and high-throughput sequencing. The CDR3 types and lengths were similar in patients and healthy controls. There was a significant difference in VJ gene usage among the three groups. Compared to the healthy neonates, the neonates with sepsis had different VJ pairs and generated different clonotypes. Although the TCR b-chain diversity was generally lower in the neonates with sepsis, there was no significant difference in TCR b-chain diversity between the patients and the healthy controls. Our data showed the characteristics of the TCR repertoire in neonates with sepsis, which represents a potentially valuable data set. This result is useful for understanding neonatal susceptibility to infection.
Introduction
Neonatal sepsis is a serious affliction leading to millions of infant deaths worldwide [1] , and enormous effort has been expended over the last 20 years to find new therapies that decrease the mortality resulting from this syndrome. It is estimated that 40% of the 3-4 million neonatal deaths that occur worldwide each year result from infections [2, 3] .
Immature immune systems are the main reason why neonates are susceptible to infection. Septic patients develop immune alterations affecting both innate and adaptive immunity [4] . The degree of immunosuppression is associated with the mortality of sepsis, and therapies that improve host immunity might increase survival [5] . However, most of the work thus far has been devoted to studying the innate component of sepsis-induced immune dysfunction.
During T cell development, the random splicing of TCR gene segments generates multiple TCR segments: Va, Ja, Vb, Db and Jb, within the TCR locus [6] . Antigen specificity is imparted through the hypervariable complementarity determining regions (CDRs) encoded within the V gene segments. Many factors can shape the TCR diversity of T cell populations [7, 8] , and TCR diversity is associated with many kinds of diseases, such as cancer [9, 10] , autoimmunity disease [11] and HIV infection [12] . TCR diversity is very important for human health; some scholars believe that ab T cell receptors can be predictors of health and disease [13] .
Some studies have confirmed that T cell receptor (TCR) diversity correlates with infection [12, 14, 15] . One of the possible mechanisms is that T cell receptor ab diversity correlates with pathogen-specific antibody levels [15] . A previous study has reported decreased T cell repertoire diversity in adult sepsis [16] . However, the T cell receptor repertoire in children and young adults shows a wide discrepancy [17] ; the characteristics of TCR diversity in neonatal sepsis are not clear.
Recently, high-throughput sequencing has revolutionized the field of genetics, permitting the investigation of complex sequencing targets at unprecedented depth and reasonable cost [18] . In this study, we investigated TCR diversity in neonatal sepsis patients by amplifying the CDR3 of the TCR b-chain using multiplex PCR followed by high-throughput sequencing.
Materials and methods
This study was approved by the ethics committee of the Children's Hospital of Fudan University. Written informed consent was acquired from the parents of all the patients. The methods were carried out in accordance with the approved guidelines. Patients and samples. The study group consisted of 20 neonates with severe sepsis, as outlined in the diagnostic criteria of the American College of Chest Physicians and the Society of Critical Care Medicine [19] . Severe sepsis is defined as sepsis with sepsis-induced organ dysfunction or tissue hypoperfusion. The patients who met the following criteria were enrolled: fever (>38.3°C) or hypothermia (core temperature <36°C), abnormal WBC count, hypotension and Lactate above 3 mM. All the patients had a positive blood culture. The control group consisted of eight matched neonates without infection. The basic demographic information of the enrolled patients is shown in Table S1 .
The enrolled neonates were divided into three groups: group 1 consisted of the neonates with sepsis, with blood collected on day 1 after diagnosis (this group was named septicaemia); group 2 consisted of the same patients but with blood collected on day 7 of antibiotic treatment (this group was named treatment), the patients who died within the diagnosed 7 days removed from the analysis; and group 3 consisted of the healthy control neonates (this group was named healthy). After the collection of 2 ml of EDTAanticoagulated blood, DNA was extracted from peripheral blood mononuclear cells, which were isolated using lymphocyte separation medium (Beyotime Biotechnology, Shanghai, China). One microgram of DNA was used for multiplex PCR and deep sequencing.
Multiplex PCR and high-throughput sequencing. To amplify the rearranged CDR3 regions of TCRb, 30 forward primers specific to functional TCR Vb FR3 regions and 13 reverse primers specific to a TCR Jb segment were designed. Five micrograms of genomic DNA was used as a template for multiplex PCR, with an equimolar pool of the 30 TCR Vb forward primers (the VbF pool) and an equimolar pool of the 13 TCR Jb reverse primers (the JbR pool). The reaction conditions were as follows: 19 Qiagen Multiplex PCR Master Mix, 0.59 Q solution, 0.2 lM VbF pool and 0.2 lM JbR pool in a 50 ll final reaction volume. The cycling conditions were as follows: 95°C for 15 min, 25-30 cycles of 30 s at 94°C, 90 s at 60°C and 30 s at 72°C, plus a final extension of 5 min at 72°C. The PCR products were loaded on a 2% agarose gel, and the 110-180 bp fractions were excised and purified.
The amplified regions were then sequenced on a highthroughput sequencing platform (Hiseq2000; Illumina, San Diego, CA, USA). We filtered the sequencing background and aligned the raw data to the V and J gene segments in the international ImMunoGeneTics (IMGT â ) database using the alignment tool (BGI) [20] . In accordance with a previous study [21] , these methods were used to correct the PCR and sequencing errors and to minimize the PCR bias among various rearranged sequences with different V and J gene families. The value of these methods was confirmed to minimize bias in the previous study [22] .
CDR3 sequence analysis. We analysed the CDR3 frequency distribution, VJ paring, VJ usage, 5 0 V/5 0 D/3 0 D/5 0 J deletion length distribution, V-D/D-J insertion length distribution, VJ base composition, CDR3 length distribution, CDR3 segmental frequency statistics and frequency of the 10 most common CDR3. To assess the similarities and differences in the TCRb repertoires of the three groups, we calculated the inverse Simpson's index of diversity, the metric overlap of TCRb CDR3 and the abundance ratios of different clonotypes.
Statistical analysis. The diversity levels and differences among groups were analysed by one-way ANOVA, and P values less than 0.05 were considered statistically significant. Wilcoxon rank sum tests were performed for the VJ pair comparison of the sepsis and healthy groups, and P values less than 0.001 were considered statistically significant.
Results

Summary of sequence data
Because some neonates with sepsis died within the diagnosed 7 days, only 10 blood samples were collected after treatment with antibiotics for 7 days. Therefore, we obtained 20, 10 and eight samples in the septicaemia, treatment and healthy groups, respectively. An average of 25 million sequencing reads was acquired from each sample, indicating that the sequence data are credible. The number of clonotypes were 149,276 AE 40,717, 106,919 AE 21,650 and 124,654 AE 28,856 in the septicaemia, treatment and healthy groups, respectively. The number of CDR3 amino acids detected was 120,256 AE 28,607, 83,490 AE 17,327 and 95,920 AE 23,274 in the septicaemia, treatment and healthy groups, respectively (Table S2) .
Analysis of the VJ Gene of the CDR3 region
V gene usage
The highly expressed V and J gene segments as well as the VJ gene pairs were analysed. Similar patterns were found in all the samples, and no significant difference was detected among the three groups. In particular, for the V gene, the TRBV20-1, TRBV2 and TRBV10-3 variants were commonly expressed in all of the samples. The top 20 V genes expressed in each sample are listed in Figure 1 . . Therefore, the distribution of the top two components of each sample was analysed. The principal component of the septicaemia samples tended to be distributed at the top right, the healthy samples tended to be distributed in the middle, and the treatment samples tended to be distributed at the left (Figure 2 ). For Component 1, there was a significant difference between the treatment group and the other two groups; for Component 2, there was a significant difference between the healthy group and the other two groups. To further confirm the results, we analysed the top two components with a Wilcoxon test. The same results were obtained (Table S3 ).
P value of the VJ gene usage difference test
One-way ANOVA and false-discovery rate (FDR) were used to analyse the differences in VJ gene usage among the three groups (Table S4 ). There was a significant difference in VJ gene usage among the three groups. The VJ gene, which had a P value ≤0.05 and an FDR ≤0.05, was cluster analysed. The healthy group and the treatment group were similar and significantly different from the septicaemia group.
Amino acid (AA) analysis of the CDR3 region
AA length and frequency distribution
The AA length distribution of all the clonotypes was analysed. We found that the length distribution of all the samples was similar ( Figure S1 ) and that all the samples lacked oligoclonal expression. Therefore, we further analysed the AA frequency distribution. The CDR3 clonotypes were further classified into five groups (rare, small, medium, large and hyperexpanded) according to their clone size [23] . The definition of rare is single-cell events; small is more than single events, but less than 0.001%; medium is from 0.001% to 0.01%; large is from 0.01% to 1%; and hyperexpanded is more than 1% [23] . Compared to the treatment group by analysis of variance (ANOVA) test in R using the aov function, the rare clonotype was more abundant in the septicaemia group (P < 0.01). After cluster analysis, we showed the results in a heat map (Figure 3) . Moreover, there was no hyperexpanded clonotype in the septicaemia group. The number of clonotypes in each sample was normalized to one million. The top 100 clonotypes are shown in Figure 4 . The most frequent clonotype was estimated at less than 50,000, accounting for less than 0.5% of the total clonotypes. Moreover, there was no difference among the groups.
Sample similarity analysis
Shannon/Inverse Simpson diversity
We used the Shannon index and inverse Simpson's index to measure the TCR repertoire diversity in the different groups. The TCR repertoire diversity in the septicaemia group was lower than that in the healthy group. However, no significant differences were found among the groups ( Figure 5 ).
Sample cluster using overlap distance
To compare the similarity of TCR repertoires among the three groups, we did sample cluster using overlap distance. We calculated the similarity between any two samples and then converted into distance and cluster analyses. The results are shown in Figure 6 . However, no significant clusters were identified among these CDR3 regions. These results indicate that the neonates with sepsis did not produce substantially different clonal proportions than the healthy neonates.
Discussion
Neonates possess a developing immune system that is different from the adult immune system. The development of the human immune system starts at an early embryonic stage. After 7 weeks of gestation, T cell progenitor cells expressing CD34 receptors migrate to the thymus and differentiate into mature subsets with CD4, CD8 and a/b TCRs [24] . A minor proportion of T cell progenitors in the foetal liver possess c/d TCRs by 6-8 weeks of gestation. In neonates, the immune system matures rapidly in the first 3 months of life and is influenced by multiple factors [25, 26] .
The diversity of the TCR and B cell receptor (BCR) repertoire is enormous, owing to the V(D)J gene rearrangement process, the random deletion of germline nucleotides and the insertion of non-template nucleotides of varying lengths between the V-D and D-J junctions or the V-J junction. It has been estimated theoretically that the diversity of TCR-ab receptors in the human thymus exceeds 10
18 [27] . The diversity of TCRs, BCRs and the secreted forms of BCRs and antibodies comprises the core of our complex immune system and serves as pivotal components of the defence mechanism protecting our bodies from different pathogens. Thus, investigating the composition and variation of the TCR repertoire in neonates is very important.
In this study, we investigated the diversity of the TCR b-chain in neonates with sepsis. The deep sequencing in this study was completed using the Illumina HiSeq platform. An average of 25 million sequencing reads was acquired from each sample. It has been reported that reaching 1 million reads ensures that the sequencing result is stable. Our data are far greater than this magnitude, so our results can be considered stable and credible. For the V gene, TRBV20-1, TRBV2 and TRBV10-3 showed the highest expression. The principal component analysis of VJ gene usage showed a significant difference among the three groups, indicating that the VJ pair is different in the Ó 2017 The Foundation for the Scandinavian Journal of Immunology different groups. Moreover, one-way ANOVA and FDR were used to confirm the P value for this difference. Compared to the healthy and treatment groups, the septicaemia group exhibited a different VJ pair. This result suggests that neonates have the ability to generate a different VJ pair after infection.
We further analysed the AA within the CDR3 region. The AA length distribution was very similar among all the groups. The septicaemia group samples showed significantly higher levels of rare frequency (single-cell events) clonotypes compared to the samples from the healthy and treatment groups. More 'rare clonotypes' signified here that the process of antigen exposure, repertoire focusing and subsequent pathogen elimination was limited, and this relates to the sepsis group. No hyperexpanded clonotypes (more than 1%) were found.
The frequency distribution for the Top 100 AA sequences was analysed. The abundance of the most frequent clonotype was less than 50,000. Compared to the normalized value of 1 million, this value is less than 0.5%. These results suggest that neonates can generate many rare new clonotypes and that their ability to generate specific hyperexpanded clonotypes for different antigens is lacking.
Finally, we performed sample similarity analysis to investigate TCR diversity. The clonotype diversity of the septicaemia group was lower than that of the healthy group. However, there was no significant difference between the two groups. A previous study has reported decreased T cell repertoire diversity in adult sepsis [16] . Our results are different from the study. We think this may be related to the following reasons: (1) T cell development is immature in neonates, and the ability of TCR clone expansion is lower than that of adults [28] ; and (2) sample size was small in our study. Using overlap distance, we also performed sample cluster analysis. There was also no significant difference among the three groups in this analysis. These results indicated that neonates could not effectively amplify clones to recognize antigens in the short term. As we know, bacterial superantigens can drive specific V region expansions. Different bacterial infections may have an effect on TCR diversity. However, due to the limited sample size, we cannot undertake the associated analysis at present.
In summary, compared to healthy neonates, neonates with sepsis have a different VJ pair and can generate Figure 5 The diversity of T cell receptor (TCR) repertoires was similar among the groups. Left is the Shannon diversity of TCR, and right is the inverse's Simpson diversity. The septicaemia group had lower diversity, but neither of them had a significant difference. Figure 6 Clustering of the samples. We calculated the similarity between any two samples and then converted into distance; no significant clusters were identified. different clonotypes. Although the diversity of the TCR b-chain was lower in the septicaemia group, it was not significantly different from that of the healthy group. Our data showed the characteristics of TCR diversity in neonates with sepsis.
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